DUBLIN – (COMMERCIAL THREAD) – “Global Embolotherapy Market 2021-2026” report has been added to ResearchAndMarkets.com offer.

The global embolotherapy market is expected to grow from $ 3.1 billion in 2021 to $ 4.3 billion by 2026 with a compound annual growth rate (CAGR) of 6.7% for the period 2021-2026 .

Companies mentioned

  • ABK Biomedical

  • Acandis GmbH

  • Balt USA LLC

  • Boston Scientific Corp.

  • Medical cook

  • Guerbet

  • Johnson & johnson

  • Kaneka Corp.

  • Medtronic Plc

  • Merit Medical Systems Inc.

  • Penumbra inc.

  • Sirtex Medical inc.

  • Stryker Corp.

  • Terumo Corp.

The report includes

  • 31 data tables and 16 additional tables

  • An overview of the global embolotherapy market with a focus on both embolic agents and supporting devices

  • Market size estimation and global market trend analysis, with data for 2019, 2020, estimates for 2021, with projections of compound annual growth rates (CAGR) to 2026

  • Highlights of Embolotherapy Market Potential, by Type, Indication, Procedure, End User, and Region

  • A detailed description of the types, history, benefits and risks associated with embolization and coverage of the relationship between minimally invasive procedures and embolotherapy

  • Identification of market drivers, restraints and other forces impacting the market and analysis of the regulatory framework and industry product recalls

  • Analysis of the market shares of key companies in the sector and coverage of their proprietary technologies, strategic alliances and other key market strategies and relevant patent analysis

Embolization is a minimally invasive procedure used for the treatment of various indications. Minimally invasive procedures are considered safe and are associated with reduced morbidity and mortality. For these reasons, there has been an increased demand for minimally invasive procedures such as embolization. In addition, it has been observed that with technological advancements there has been a growth of embolic agents and their use. The market has witnessed a dramatic shift in the use of embolic agents, from initial candidates such as autologous blood clots to newer agents such as microspheres, coils, gels and liquids. Compared to the 1990s, embolotherapy now encompasses a wide range of indications, and embolization has, through a series of technological advances, gained in importance. Indeed, with high quality microcatheters and microfilms, even the distal areas can be reached.

Embolotherapy is considered the first line of treatment for indications such as gastrointestinal bleeding, hemorrhage, etc. Procedures such as prostatic artery embolization, bariatric embolization, hemorrhoid embolization and the like have also gained prominence over time. For patients with hepatocellular carcinoma, embolization is considered the treatment of choice for patients awaiting transplantation. Apart from this, even in oncology, procedures such as radioembolization and embolization with drug eluting beads are increasingly common and are contributing to the growth of the market.

Some of the major players in this market are Boston Scientific, Medtronic, Stryker Corp., Terumo Corp., Merit Medical Systems, Cook Medical, and Johnson & Johnson. The market has also seen approvals for many embolic agents and support devices as well as large company mergers and acquisitions. All of these factors are positively contributing to the growth of the market. Some of the approvals obtained in 2021 include Terumo’s Azur Vascular Stopper and PG Pro Microcatheter Embolization System, which have been approved in the United States; Scitech Medical’s Embosoft microspheres have received CE mark approval; Embolx Sniper Occlusion Balloon launched in Europe; and Shape Memory Medical’s Impede-FX embolization plug received PMDA approval.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview of Embolotherapy

  • Overview

  • Types of embolic agents

  • Permanent agents

  • Temporary agents

  • History of embolotherapy

  • Benefits of embolization

  • Risks of embolization

Chapter 4 Market Dynamics

  • Market factors

  • Growing demand for minimally invasive procedures

  • Technological advances

  • Growing prevalence of target indications

  • Market constraints

  • Lack of qualified interventional radiologists

  • Complications associated with embolotherapy

  • Unconscious

  • Market recalls

Chapter 5 Market breakdown by product type

  • Overview

  • Market analysis

  • Global Embolotherapy Market by Product Type

  • Global Embolotherapy Market Shares by Product Type

Chapter 6 Market breakdown by indication

  • Overview

  • Market analysis

  • Global Embolotherapy Market Share by Indication

Chapter 7 Market breakdown by procedure

  • Overview

  • Market analysis

  • Global Embolotherapy Market Shares by Procedure Type

Chapter 8 Market Breakdown by End User

  • Overview

  • Market analysis

  • Global Embolotherapy Market Shares by End User Type

Chapter 9 Market Breakdown by Region

Chapter 10 Competitive Landscape

  • Mergers and Acquisitions

  • Key developments

  • Global Company Share Analysis

  • Impact of COVID-19 on the Embolotherapy market

Chapter 11 Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/c9xd76

Leave a Reply

Your email address will not be published.